TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Tumor necrosis factor (TNF) is the prototypic pro-inflammatory cytokine. It is central to host defense and inflammatory responses but under certain circumstances also triggers cell death and tissue degeneration. Its pleiotropic effects often lead to opposing outcomes during the development of immune-mediated diseases, particularly those affecting the central nervous system (CNS). The reported contradictions may result from lack of precision in discussing TNF. TNF signaling comprises at minimum a two-ligand (soluble and transmembrane TNF) and two-receptor (TNFR1 and TNFR2) system, with ligands and receptors both differentially expressed and regulated on different cell types. The "functional multiplicity" this engenders is the focus of much research, but there is still no general consensus on functional outcomes of TNF signaling in general, let alone in the CNS. In this review, evidence showing the effects of TNF in the CNS under physiological and pathophysiological conditions is placed in the context of major advances in understanding of the cellular and molecular mechanisms that govern TNF function in general. Thus the roles of TNF signaling in the CNS shift from the conventional dichotomy of beneficial and deleterious, that mainly explain effects under pathological conditions, to incorporate a growing number of "essential" and "desirable" roles for TNF and its main cellular source in the CNS, microglia, under physiological conditions including regulation of neuronal activity and maintenance of myelin. An improved holistic view of TNF function in the CNS might better reconcile the expansive experimental data with stark clinical evidence that reduced functioning of TNF and its dominant pro-inflammatory receptor, TNFR1, are risk factors for the development of multiple sclerosis. It will also facilitate the safe translation of basic research findings from animal models to humans and propel the development of more selective anti-TNF therapies aimed at selectively inhibiting deleterious effects of this cytokine while maintaining its essential and desirable ones, in the periphery and the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931
The Pathophysiology Of Tumor Necrosis Factors
VASSALLI, P. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.411 · Cited by 1,920
Apoptosis in the nervous system
Yuan, J., & Yankner, B. A. (2000) · Nature · doi:10.1038/35037739 · Cited by 1,877
Tripartite synapses: astrocytes process and control synaptic information
Perea, G., Navarrete, M., & Araque, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.001 · Cited by 1,820
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
Synaptic scaling mediated by glial TNF-α
Stellwagen, D., & Malenka, R. C. (2006) · Nature · doi:10.1038/nature04671 · Cited by 1,715
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Self-citationSignal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., & Nabekura, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-08.2009 · Cited by 1,619
Microglial interactions with synapses are modulated by visual experience
Tremblay, M.-È., Lowery, R. L., & Majewska, A. K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000527 · Cited by 1,542
The self-tuning neuron: synaptic scaling of excitatory synapses
Turrigiano, G. G. (2008) · Cell · doi:10.1016/j.cell.2008.10.008 · Cited by 1,533
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
McDermott, M. F., Aksentijevich, I., Galon, J., McDermott, E. M., Ogunkolade, B. W., Centola, M., Mansfield, E., Gadina, M., Karenko, L., Pettersson, T., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80721-7 · Cited by 1,408
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
Selmaj, K. W., & Raine, C. S. (1988) · Annals of Neurology · doi:10.1002/ana.410230405 · Cited by 1,368
Control of Synaptic Strength by Glial TNFα
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S., & Malenka, R. C. (2002) · Science · doi:10.1126/science.1067859 · Cited by 1,344
Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., & Kollias, G. (1999) · Immunity · doi:10.1016/s1074-7613(00)80038-2 · Cited by 1,344
Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,325
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
BIRAC Consortium, Stahl, E. A., YEAR Consortium, Raychaudhuri, S., Remmers, E. F., Xie, G., Eyre, S., Thomson, B. P., Li, Y., Kurreeman, F. A. S., et al. (2010) · Nature Genetics · doi:10.1038/ng.582 · Cited by 1,253
Rothe, J., Lesslauer, W., Lötscher, H., Lang, Y., Koebel, P., Köntgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., & Bluethmann, H. (1993) · Nature · doi:10.1038/364798a0 · Cited by 1,245
Cytokines and endothelial cell biology
Pober, J. S., & Cotran, R. S. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.427 · Cited by 1,242
Pasparakis, M., Alexopoulou, L., Episkopou, V, & Kollias, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1397 · Cited by 1,160
Kriegler, M., Perez, C., DeFay, K., Albert, I., & Lu, S. D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,102
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40
Rothe, M., Sarma, V., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,051
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048
Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2 (2010) · Nature Genetics · doi:10.1038/ng.694 · Cited by 1,047
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932
Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 921
NF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877
Tumor Necrosis Factor-α: A Mediator of Focal Ischemic Brain Injury
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., & Feuerstein, G. Z. (1997) · Stroke · doi:10.1161/01.str.28.6.1233 · Cited by 863
International Genetics of Ankylosing Spondylitis Consortium (IGAS) (2013) · Nature Genetics · doi:10.1038/ng.2667 · Cited by 860
McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 847
Beutler, B., Mahoney, J., Le Trang, N., Pekala, P., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.984 · Cited by 821
Sharief, M. K., & Hentges, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250704 · Cited by 809
Tumor necrosis factor identified in multiple sclerosis brain.
Hofman, F. M., Hinton, D. R., Johnson, K., & Merrill, J. E. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.607 · Cited by 801
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
Tumor necrosis factor-alpha expression in ischemic neurons.
Liu, T., Clark, R. K., McDonnell, P. C., Young, P. R., White, R. F., Barone, F. C., & Feuerstein, G. Z. (1994) · Stroke · doi:10.1161/01.str.25.7.1481 · Cited by 797
Lieberman, A. P., Pitha, P. M., Shin, H. S., & Shin, M. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6348 · Cited by 783
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
Selmaj, K., Raine, C. S., Cannella, B., & Brosnan, C. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115102 · Cited by 738
van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M. E., Woody, J. N., Hartung, H.-P., & Polman, C. H. (1996) · Neurology · doi:10.1212/wnl.47.6.1531 · Cited by 733
TNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation
Peschon, J. J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P. J., Ware, C. B., & Mohler, K. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.943 · Cited by 706
Ruddle, N. H., Bergman, C. M., McGrath, K. M., Lingenheld, E. G., Grunnet, M. L., Padula, S. J., & Clark, R. B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1193 · Cited by 688
Cheng, B., Christakos, S., & Mattson, M. P. (1994) · Neuron · doi:10.1016/0896-6273(94)90159-7 · Cited by 668
The influence of cytokines on the integrity of the blood-brain barrier in vitro
de Vries, H. E., Blom-Roosemalen, M. C. M., Oosten, M. V., de Boer, A. G., van Berkel, T. J. C., Breimer, D. D., & Kuiper, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00148-4 · Cited by 665
Björkqvist, M., Wild, E. J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R. V., Benn, C. L., Soulet, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080178 · Cited by 650
Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 631
Production of tumor necrosis factor-alpha by microglia and astrocytes in culture
Sawada, M., Kondo, N., Suzumura, A., & Marunouchi, T. (1989) · Brain Research · doi:10.1016/0006-8993(89)90078-4 · Cited by 631
CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity
Rogers, J. T., Morganti, J. M., Bachstetter, A. D., Hudson, C. E., Peters, M. M., Grimmig, B. A., Weeber, E. J., Bickford, P. C., & Gemma, C. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3667-11.2011 · Cited by 624
Molecular Cloning of the Complementary DNA for Human Tumor Necrosis Factor
Wang, A. M., Creasey, A. A., Ladner, M. B., Lin, L. S., Strickler, J., Van Arsdell, J. N., Yamamoto, R., & Mark, D. F. (1985) · Science · doi:10.1126/science.3856324 · Cited by 622
Characterization of tumor necrosis factor-deficient mice
Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8093 · Cited by 622
Chung, I. Y., & Benveniste, E. N. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.8.2999 · Cited by 609
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C. F., Schreiber, R. D., Goeddel, D. V., & Moore, M. W. (1994) · Nature · doi:10.1038/372560a0 · Cited by 588
Fontaine, V., Mohand-Said, S., Hanoteau, N., Fuchs, C., Pfizenmaier, K., & Eisel, U. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-j0001.2002 · Cited by 585
Induced Tolerance to Ischemia in Gerbil Hippocampal Neurons
Kirino, T., Tsujita, Y., & Tamura, A. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.62 · Cited by 582
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
Gutierrez, E. G., Banks, W. A., & Kastin, A. J. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90027-v · Cited by 577
Lewis, M., Tartaglia, L. A., Lee, A., Bennett, G. L., Rice, G. C., Wong, G. H., Chen, E. Y., & Goeddel, D. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2830 · Cited by 567
Mattson, M. P., Goodman, Y., Luo, H., Fu, W., & Furukawa, K. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6<681::aid-jnr3>3.0.co;2-3 · Cited by 567
Reciprocal Regulation between Resting Microglial Dynamics and Neuronal Activity In Vivo
Li, Y., Du, X.-F., Liu, C.-S., Wen, Z.-L., & Du, J.-L. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.10.027 · Cited by 562
Death receptor signal transducers: nodes of coordination in immune signaling networks
Wilson, N. S., Dixit, V., & Ashkenazi, A. (2009) · Nature Immunology · doi:10.1038/ni.1714 · Cited by 559
Immune proteins in brain development and synaptic plasticity
Boulanger, L. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.001 · Cited by 555
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Chen, X., Bäumel, M., Männel, D. N., Howard, O. M. Z., & Oppenheim, J. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.154 · Cited by 548
Li, Z., Jo, J., Jia, J.-M., Lo, S.-C., Whitcomb, D. J., Jiao, S., Cho, K., & Sheng, M. (2010) · Cell · doi:10.1016/j.cell.2010.03.053 · Cited by 532
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
Elevated circulating tumor necrosis factor levels in Alzheimer's disease
Fillit, H., Ding, W., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., & Wolf-Klein, G. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90490-k · Cited by 512
“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506
The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis
Vandenabeele, P., Declercq, W., Van Herreweghe, F., & Vanden Berghe, T. (2010) · Science Signaling · doi:10.1126/scisignal.3115re4 · Cited by 482
Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
Selmaj, K., Raine, C. S., & Cross, A. H. (1991) · Annals of Neurology · doi:10.1002/ana.410300510 · Cited by 436
Martin-Villalba, A., Herr, I., Jeremias, I., Hahne, M., Brandt, R., Vogel, J., Schenkel, J., Herdegen, T., & Debatin, K.-M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03809.1999 · Cited by 434
Marchetti, L., Klein, M., Schlett, K., Pfizenmaier, K., & Eisel, U. L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311766200 · Cited by 427
Kaneko, M., Stellwagen, D., Malenka, R. C., & Stryker, M. P. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.023 · Cited by 405
Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G., & Kollias, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11294 · Cited by 403
Self-citationLinker, R. A., Mäurer, M., Gaupp, S., Martini, R., Holtmann, B., Giess, R., Rieckmann, P., Lassmann, H., Toyka, K. V., Sendtner, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0602-620 · Cited by 398
He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705042 · Cited by 390
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 384
Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes
Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E., & Romagnani, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020110 · Cited by 379
Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor
Lambertsen, K. L., Clausen, B. H., Babcock, A. A., Gregersen, R., Fenger, C., Nielsen, H. H., Haugaard, L. S., Wirenfeldt, M., Nielsen, M., Dagnaes-Hansen, F., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5505-08.2009 · Cited by 370
TNFα Controls Glutamatergic Gliotransmission in the Hippocampal Dentate Gyrus
Santello, M., Bezzi, P., & Volterra, A. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.003 · Cited by 362
Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362
McCoy, M. K., Martinez, T. N., Ruhn, K. A., Szymkowski, D. E., Smith, C. G., Botterman, B. R., Tansey, K. E., & Tansey, M. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1504-06.2006 · Cited by 354
Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
D'Souza, S. D., Bonetti, B., Balasingam, V., Cashman, N. R., Barker, P. A., Troutt, A. B., Raine, C. S., & Antel, J. P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2361 · Cited by 354
‘Ischemic tolerance’ phenomenon detected in various brain regions
Kitagawa, K., Matsumoto, M., Kuwabara, K., Tagaya, M., Ohtsuki, T., Hata, R., Ueda, H., Handa, N., Kimura, K., & Kamada, T. (1991) · Brain Research · doi:10.1016/0006-8993(91)91596-s · Cited by 338
Chen, X., Subleski, J. J., Kopf, H., Howard, O. M. Z., Männel, D. N., & Oppenheim, J. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6467 · Cited by 335
Kassiotis, G., & Kollias, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.427 · Cited by 332
Studies of endotoxin-induced decrease in lipoprotein lipase activity.
Kawakami, M., & Cerami, A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.631 · Cited by 327
Akassoglou, K., Bauer, J., Kassiotis, G., Pasparakis, M., Lassmann, H., Kollias, G., & Probert, L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65622-2 · Cited by 316
Self-citationHuman brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
Nitsch, R., Bechmann, I., Deisz, R. A., Haas, D., Lehmann, T. N., Wendling, U., & Zipp, F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02659-3 · Cited by 300
Tartaglia, L. A., Goeddel, D. V., Reynolds, C., Figari, I. S., Weber, R. F., Fendly, B. M., & Palladino, M. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.4637 · Cited by 289
Mohammed, F. F., Smookler, D. S., Taylor, S. E. M., Fingleton, B., Kassiri, Z., Sanchez, O. H., English, J. L., Matrisian, L. M., Au, B., Yeh, W.-C., et al. (2004) · Nature Genetics · doi:10.1038/ng1413 · Cited by 285
Tasaki, K., Ruetzler, C. A., Ohtsuki, T., Martin, D., Nawashiro, H., & Hallenbeck, J. M. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01383-2 · Cited by 281
Microglia Actively Regulate the Number of Functional Synapses
Ji, K., Akgul, G., Wollmuth, L. P., & Tsirka, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056293 · Cited by 280
Shohami, E., Bass, R., Wallach, D., Yamin, A., & Gallily, R. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00004 · Cited by 280
McAlpine, F. E., Lee, J.-K., Harms, A. S., Ruhn, K. A., Blurton-Jones, M., Hong, J., Das, P., Golde, T. E., LaFerla, F. M., Oddo, S., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.006 · Cited by 268
Expression of TNF and TNF Receptors (p55 and p75) in the Rat Brain after Focal Cerebral Ischemia
Botchkina, G. I., Meistrell, M. E., Botchkina, I. L., & Tracey, K. J. (1997) · Molecular Medicine · doi:10.1007/bf03401714 · Cited by 265
Rouzer, C. A., & Cerami, A. (1980) · Molecular and Biochemical Parasitology · doi:10.1016/0166-6851(80)90046-8 · Cited by 258
Akassoglou, K., Probert, L., Kontogeorgos, G., & Kollias, G. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.1.438 · Cited by 256
Self-citationInactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants
Steed, P. M., Tansey, M. G., Zalevsky, J., Zhukovsky, E. A., Desjarlais, J. R., Szymkowski, D. E., Abbott, C., Carmichael, D., Chan, C., Cherry, L., et al. (2003) · Science · doi:10.1126/science.1081297 · Cited by 256
Furukawa, K., & Mattson, M. P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051876.x · Cited by 253
Gary, D. S., Bruce-Keller, A. J., Kindy, M. S., & Mattson, M. P. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199812000-00001 · Cited by 249
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration
Tobinick, E. L., & Gross, H. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-2 · Cited by 248
Pribiag, H., & Stellwagen, D. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0530-13.2013 · Cited by 247
Ruuls, S. R., Hoek, R. M., Ngo, V. N., McNeil, T., Lucian, L. A., Janatpour, M. J., Körner, H., Scheerens, H., Hessel, E. M., Cyster, J. G., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00215-1 · Cited by 246
Leist, T. P., Frei, K., Kam-Hansen, S., Zinkernagel, R. M., & Fontana, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1743 · Cited by 244
Körner, H., Riminton, D. S., Strickland, D. H., Lemckert, F. A., Pollard, J. D., & Sedgwick, J. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1585 · Cited by 238
Tumor necrosis factor‐α antagonists and neuropathy
Stübgen, J. (2008) · Muscle & Nerve · doi:10.1002/mus.20924 · Cited by 236
Baker, D., Butler, D., Scallon, B. J., O'Neill, J. K., Turk, J. L., & Feldmann, M. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240916 · Cited by 229
Breder, C. D., Tsujimoto, M., Terano, Y., Scott, D. W., & Saper, C. B. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903370403 · Cited by 226
TNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer
Walczak, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01066.x · Cited by 226
Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2006) · The FASEB Journal · doi:10.1096/fj.05-5106com · Cited by 222
Ferguson, A. R., Christensen, R. N., Gensel, J. C., Miller, B. A., Sun, F., Beattie, E. C., Bresnahan, J. C., & Beattie, M. S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3708-08.2008 · Cited by 219
Cauwels, A., Janssen, B., Waeytens, A., Cuvelier, C., & Brouckaert, P. (2003) · Nature Immunology · doi:10.1038/ni914 · Cited by 217
Neuronal Damage in Autoimmune Neuroinflammation Mediated by the Death Ligand TRAIL
Aktas, O., Smorodchenko, A., Brocke, S., Infante-Duarte, C., Topphoff, U. S., Vogt, J., Prozorovski, T., Meier, S., Osmanova, V., Pohl, E., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.018 · Cited by 217
Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1
Eugster, H.-P., Frei, K., Bachmann, R., Bluethmann, H., Lassmann, H., & Fontana, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199902)29:02<626::aid-immu626>3.0.co;2-a · Cited by 213
Pathobiology of injury after stroke: the neurovascular unit and beyond
Dirnagl, U. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06691.x · Cited by 212
Brambilla, R., Ashbaugh, J. J., Magliozzi, R., Dellarole, A., Karmally, S., Szymkowski, D. E., & Bethea, J. R. (2011) · Brain · doi:10.1093/brain/awr199 · Cited by 210
Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
Waldner, H., Sobel, R. A., Howard, E., & Kuchroo, V. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3100 · Cited by 199
Rabbit tumor necrosis factor: mechanism of action
Ruff, M. R., & Gifford, G. E. (1981) · Infection and Immunity · doi:10.1128/iai.31.1.380-385.1981 · Cited by 196
Frei, K., Eugster, H.-P., Bopst, M., Constantinescu, C. S., Lavi, E., & Fontana, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2177 · Cited by 195
Weiss, T., Grell, M., Hessabi, B., Bourteele, S., Müller, G., Scheurich, P., & Wajant, H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2398 · Cited by 185
Circulating Antibody against Tumor Necrosis Factor–Alpha Protects Rat Brain from Reperfusion Injury
Lavine, S. D., Hofman, F. M., & Zlokovic, B. V. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199801000-00005 · Cited by 183
Tissue Distribution of the Death Ligand TRAIL and Its Receptors
Spierings, D. C., de Vries, E. G., Vellenga, E., van den Heuvel, F. A., Koornstra, J. J., Wesseling, J., Hollema, H., & de Jong, S. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.3a6112.2004 · Cited by 183
Selmaj, K., Papierz, W., Glabinski, A., & Kohno, T. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00139-f · Cited by 177
Ogoshi, F., Yin, H. Z., Kuppumbatti, Y. S., Song, B., Amindari, S., & Weiss, J. H. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.026 · Cited by 174
Grimaldi, L. M. E., Martino, G. V., Franciotta, D. M., Brustia, R., Castagna, A., Pristerà, R., & Lazzarin, A. (1991) · Annals of Neurology · doi:10.1002/ana.410290106 · Cited by 172
Hövelmeyer, N., Hao, Z., Kranidioti, K., Kassiotis, G., Buch, T., Frommer, F., von Hoch, L., Kramer, D., Minichiello, L., Kollias, G., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5875 · Cited by 170
The presence of tumour necrosis factor in CSF and plasma after severe head injury
Ross, S. A., Halliday, M. I., Campbell, G. C., Byrnes, D. P., & Rowlands, B. J. (1994) · British Journal of Neurosurgery · doi:10.3109/02688699408995109 · Cited by 169
Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia.
Meistrell, M. E., Botchkina, G. I., Wang, H., Santo, E. D., Cockroft, K. M., Bloom, O., Vishnubhakat, J. M., Ghezzi, P., & Tracey, K. J. (1997) · PubMed · Cited by 168
Picarella, D. E., Kratz, A., Li, C. B., Ruddle, N. H., & Flavell, R. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.4136 · Cited by 168
Neuroprotective effects of TNF binding protein in focal cerebral ischemia
Nawashiro, H., Martin, D. A., & Hallenbeck, J. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00981-5 · Cited by 162
Suvannavejh, G. C., Lee, H.-O., Padilla, J., Dal Canto, M. C., Barrett, T. A., & Miller, S. D. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1706 · Cited by 160
Zalevsky, J., Secher, T., Ezhevsky, S. A., Janot, L., Steed, P. M., O’Brien, C., Eivazi, A., Kung, J., Nguyen, D.-H. T., Doberstein, S. K., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1872 · Cited by 157
Sabelko, K. A., Kelly, K. A., Nahm, M. H., Cross, A. H., & Russell, J. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3096 · Cited by 150
Grell, M., Becke, F. M., Wajant, H., Männel, D. N., & Scheurich, P. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<257::aid-immu257>3.0.co;2-g · Cited by 150
Taupin, V., Renno, T., Bourbonnière, L., Peterson, A. C., Rodriguez, M., & Owens, T. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270416 · Cited by 140
Monoclonal antibody therapy-associated neurological disorders
the BIOGEAS Study Group, Bosch, X., Saiz, A., & Ramos‐Casals, M. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.1 · Cited by 137
Patel, J. R., Williams, J. L., Muccigrosso, M. M., Liu, L., Sun, T., Rubin, J. B., & Klein, R. S. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1034-0 · Cited by 134
Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease
Hsiao, H.-Y., Chiu, F.-L., Chen, C.-M., Wu, Y.-R., Chen, H.-M., Chen, Y.-C., Kuo, H.-C., & Chern, Y. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu151 · Cited by 134
Leonoudakis, D., Zhao, P., & Beattie, E. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5159-07.2008 · Cited by 132
Signaling by death receptors in the nervous system
Haase, G., Pettmann, B., Raoul, C., & Henderson, C. E. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.07.013 · Cited by 131
A TNF Receptor 2 Selective Agonist Rescues Human Neurons from Oxidative Stress-Induced Cell Death
Fischer, R., Maier, O., Siegemund, M., Wajant, H., Scheurich, P., & Pfizenmaier, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027621 · Cited by 129
Paganelli, R., Iorio, A. D., Patricelli, L., Ripani, F., Sparvieri, E., Faricelli, R., Iarlori, C., Porreca, E., Gioacchino, M. D., & Abate, G. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00191-7 · Cited by 128
An Adaptive Role of TNFα in the Regulation of Striatal Synapses
Lewitus, G. M., Pribiag, H., Duseja, R., St-Hilaire, M., & Stellwagen, D. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3481-13.2014 · Cited by 128
Jurewicz, A., Matysiak, M., Tybor, K., Kilianek, L., Raine, C. S., & Selmaj, K. (2005) · Brain · doi:10.1093/brain/awh627 · Cited by 127
TUMOR NECROSIS FACTOR IS A BRAIN DAMAGING CYTOKINE IN CEREBRAL ISCHEMIA
Meistrell, M. E., Botchkina, G. I., Wang, H., Santo, E. D., Cockroft, K. M., Bloom, O., Vishnubhakat, J. M., Ghezzi, P., & Tracey, K. J. (1997) · Shock · doi:10.1097/00024382-199711000-00005 · Cited by 125
Barnum, C. J., Chen, X., Chung, J., Chang, J., Williams, M., Grigoryan, N., Tesi, R. J., & Tansey, M. G. (2014) · Journal of Parkinson's Disease · doi:10.3233/jpd-140410 · Cited by 124
Fischer, R., Wajant, H., Kontermann, R., Pfizenmaier, K., & Maier, O. (2014) · Glia · doi:10.1002/glia.22605 · Cited by 124
Alexopoulou, L., Kranidioti, K., Xanthoulea, S., Denis, M., Kotanidou, A., Douni, E., Blackshear, P. J., Kontoyiannis, D. L., & Kollias, G. (2006) · European Journal of Immunology · doi:10.1002/eji.200635921 · Cited by 123
Körner, H., Lemckert, F. A., Chaudhri, G., Etteldorf, S., & Sedgwick, J. D. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270822 · Cited by 120
Dörr, J. R., Bechmann, I., Waiczies, S., Aktaş, O., Walczak, H., Krammer, P. H., Nitsch, R., & Zipp, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-j0001.2002 · Cited by 116
Clausen, B. H., Degn, M., Martin, N. A., Couch, Y., Karimi, L., Ormhøj, M., Mortensen, M.-L. B., Gredal, H., Gardiner, C., Sargent, I. I. L., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/preaccept-2982253041347736 · Cited by 111
McCann, F. E., Perocheau, D. P. B., Ruspi, G., Blazek, K. D., Davies, M. L., Feldmann, M., Dean, J. L. E., Stoop, A. A., & Williams, R. O. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38755 · Cited by 110
Black, R. A. (2004) · Nature Genetics · doi:10.1038/ng0904-934 · Cited by 103
Taoufik, E., Petit, E., Divoux, D., Tseveleki, V., Mengozzi, M., Roberts, M. L., Valable, S., Ghezzi, P., Quackenbush, J., Brines, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801447105 · Cited by 103
Self-citationMalipiero, U., Frei, K., Spanaus, K., Agresti, C., Lassmann, H., Hahne, M., Tschopp, J., Eugster, H., & Fontana, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271211 · Cited by 102
Su, X., Wang, H., Kang, D., Zhu, J., Sun, Q., Li, T., & Ding, K. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1510-0 · Cited by 100
Shen, Y., Li, R., & Shiosaki, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3550 · Cited by 99
Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy
Fischer, R., Kontermann, R. E., & Maier, O. (2015) · Antibodies · doi:10.3390/antib4010048 · Cited by 99
Apoptotic and Anti‐Apoptotic Synaptic Signaling Mechanisms
Mattson, M. P. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00264.x · Cited by 98
Kassiotis, G., Pasparakis, M., Kollias, G., & Probert, L. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199903)29:03<774::aid-immu774>3.0.co;2-t · Cited by 97
Self-citationHe, P., Liu, Q., Wu, J., & Shen, Y. (2012) · The FASEB Journal · doi:10.1096/fj.11-192716 · Cited by 97
Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils.
Porteu, F., & Hieblot, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42018-7 · Cited by 96
Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP
Rousselet, E., Callebert, J., Parain, K., Joubert, C., Hunot, S., Hartmann, A., Jacque, C., Pérez-Díaz, F., Cohen‐Salmon, C., Launay, J., et al. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7960 · Cited by 94
Necroptosis Mediates TNF-Induced Toxicity of Hippocampal Neurons
Liu, S., Wang, X., Li, Y., Xu, L., Yu, X., Ge, L., Li, J., Zhu, Y., & He, S. (2014) · BioMed Research International · doi:10.1155/2014/290182 · Cited by 94
Taoufik, E., Tseveleki, V., Chu, S. Y., Tselios, T., Karin, M., Lassmann, H., Szymkowski, D. E., & Probert, L. (2011) · Brain · doi:10.1093/brain/awr203 · Cited by 94
Self-citationBartsch, J. W., Wildeboer, D., Koller, G., Naus, S., Rittger, A., Moss, M. L., Minai, Y., & Jockusch, H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1520-10.2010 · Cited by 94
Akassoglou, K., Douni, E. K., Bauer, J., Lassmann, H., Kollias, G. A., & Probert, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0236046100 · Cited by 90
Self-citationAntibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis
Williams, S. K., Maier, O., Fischer, R., Fairless, R., Hochmeister, S., Stojic, A., Pick, L., Haar, D., Musiol, S., Storch, M. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090117 · Cited by 86
Steeland, S., Puimège, L., Vandenbroucke, R. E., Hauwermeiren, F. V., Haustraete, J., Devoogdt, N., Hulpiau, P., Leroux-Roels, G. G., Laukens, D., Meuleman, P., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.617787 · Cited by 82
Gourin, C. G., & Shackford, S. R. (1997) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199706000-00020 · Cited by 81
Yu, Z., Cheng, G., Wen, X., Wu, G. D., Lee, W.-T., & Pleasure, D. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0530 · Cited by 80
Novrup, H. G., Bracchi-Ricard, V. C., Ellman, D. G., Ricard, J., Jain, A., Runko, E., Lyck, L., Yli-Karjanmaa, M., Szymkowski, D. E., Pearse, D. D., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0159-6 · Cited by 76
FLIPL Protects Neurons against In Vivo Ischemia and In Vitro Glucose Deprivation-Induced Cell Death
Taoufik, E., Valable, S., Muller, G. J., Roberts, M. L., Divoux, D., Tinel, A., Voulgari-Kokota, A., Tseveleki, V., Altruda, F., Lassmann, H., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1091-07.2007 · Cited by 75
Self-citationMembrane Tumor Necrosis Factor Confers Partial Protection to Listeria Infection
Torres, D., Janot, L., Quesniaux, V. F. J., Grivennikov, S. I., Maillet, I., Sedgwick, J. D., Ryffel, B., & Erard, F. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61250-3 · Cited by 75
Raine, C. S., Bonetti, B., & Cannella, B. (1998) · PubMed · Cited by 75
Körner, H., Goodsall, A. L., Lemckert, F. A., Scallon, B. J., Ghrayeb, J., Ford, A. L., & Sedgwick, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.11066 · Cited by 69
Medvedev, A. E., Sundan, A., & Espevik, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241139 · Cited by 69
Neuroprotection with a Brain-Penetrating Biologic Tumor Necrosis Factor Inhibitor
Zhou, Q.-H., Sumbria, R. K., Hui, E. K., Lu, J. Z., Boado, R. J., & Pardridge, W. M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185876 · Cited by 68
Oligodendrocyte-Specific FADD Deletion Protects Mice from Autoimmune-Mediated Demyelination
Mc Guire, C., Volckaert, T., Wolke, U., Sze, M., de Rycke, R., Waisman, A., Prinz, M., Beyaert, R., Pasparakis, M., & van Loo, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000930 · Cited by 66
Cited by
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,694
TNF biology, pathogenic mechanisms and emerging therapeutic strategies
Kalliolias, G. D., & Ivashkiv, L. B. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,387
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution
Mathys, H., Adaikkan, C., Gao, F., Young, J. Z., Manet, E., Hemberg, M., De Jager, P. L., Ransohoff, R. M., Regev, A., & Tsai, L.-H. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.039 · Cited by 740
Hellenbrand, D. J., Quinn, C. M., Piper, Z. J., Morehouse, C. N., Fixel, J. A., & Hanna, A. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02337-2 · Cited by 635
Metadata
- Authors
- Probert, L.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 302
- Pages
- 2-22
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W823098362
- Cited by
- 495
- References
- 221
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.